Interestingly, two-thirds of Croatian hematologists also perform phlebotomies in JAK2-positive ET patients, as well as in primary MF and post-PV MF patients with hematocrit levels higher than 45%. This evidence concerns the gene JAK2 and essential thrombocythemia.